In this guide
What is a digestive enzyme blend?
Digestive enzyme supplements provide proteins that break down particular food substrates. A blend may combine proteases, lipases, amylases, lactase, alpha-galactosidase and other enzymes from microbial, plant or animal sources.
The category includes products with very different purposes. A targeted lactase or alpha-galactosidase product can be tied to a specific meal component. A proprietary broad blend may add herbs and disclose incomplete activity data. Prescription pancreatic enzyme replacement therapy (PERT) is a regulated treatment for diagnosed exocrine pancreatic insufficiency and belongs in a separate clinical pathway.
Typical Digestive Enzyme Blend Protocols
| Source and context | Material | Amount | Frequency | Duration | Observed result |
|---|---|---|---|---|---|
| Di Stefano 2007 · cooked-bean challenge | Oral alpha-galactosidase | 300 or 1,200 GalU | With one test meal containing 420 g cooked beans | 8-hour observation | 1,200 GalU reduced breath hydrogen and flatulence; both doses reduced total symptom score Eight healthy volunteers in a randomized double-blind placebo-controlled challenge; very small mechanistic meal study. |
| Böhn 2021 · IBS carbohydrate-rich meal challenge | Alpha-galactosidase capsules | 1,200 GalU per meal | 3 capsules with the first bites of each of 3 standardized high-oligosaccharide meals | 7.5-hour measurement day | No clear superiority for overall GI symptoms versus placebo 20 adults, 19 women, in a randomized double-blind crossover pilot; targeted enzyme did not produce a universal IBS response. |
| Martin-Biggers 2024 · occasional post-meal bloating | Flatter Me: proprietary 18-enzyme blend plus ginger, fennel and peppermint | 1 capsule | With one standardized cheese-pizza meal per crossover visit | Single-use; visits 1 week apart | Measured abdominal distension favored product at 30 and 90 minutes; subjective symptoms were not significant 20 completers; industry funded and author employed by sponsor. The herbs and enzymes prevent ingredient-specific attribution. |
No RDA, AI or UL exists. Units such as GalU, ALU, HUT, FIP, FCC or USP are assay-specific and cannot be converted to milligrams or to one another without a validated method.
- Target
- Record the food substrate: lactose, oligosaccharides, fat, starch or protein.
- Activity
- Record each enzyme’s named activity unit, not only total blend milligrams.
- Timing
- Keep before-meal, first-bite or with-meal instructions attached to the source.
- Product
- Record enzyme sources, enteric coating, herbs, allergens, lot and storage.
Match the enzyme to the substrate
What are digestive enzymes commonly used for?
Targeted products are used for lactose or oligosaccharide intolerance. Broad blends are marketed for bloating, fullness and “general digestion,” but effects cannot be predicted from the number of enzymes on the label. [1][2][3][4]
Clinical enzyme replacement is different. PERT treats documented pancreatic insufficiency in conditions such as cystic fibrosis or chronic pancreatitis; abdominal pain alone is not proof of insufficiency. [3][5]
Which forms and labels matter?
Look for named enzymes, source organism or tissue, activity units at end of shelf life, dose per capsule, coating, allergens and co-ingredients. Protease from fungal fermentation, porcine pancreatin, bromelain and papain have different activity profiles and allergy implications.
“Proprietary blend 500 mg” is inadequate when individual activities are absent. Acid resistance and enteric release can matter, especially for lipase, but a coating claim still does not prove clinical performance.
What does the human evidence show?
Di Stefano et al. gave eight healthy adults placebo, 300 GalU or 1,200 GalU alpha-galactosidase with 420 g cooked beans. Over eight hours, 1,200 GalU reduced breath hydrogen and flatulence severity. Both active doses reduced the combined symptom score. The tiny controlled challenge supports a substrate-specific effect, not daily broad-blend use. [1]
Böhn et al. tested 1,200 GalU as three 400-GalU capsules with the first bites of each of 3 standardized high-oligosaccharide meals in 20 adults with IBS. In this double-blind crossover pilot, alpha-galactosidase was not clearly superior to placebo for overall symptoms, showing that reducing one substrate does not resolve every IBS mechanism. [2]
Martin-Biggers studied a commercial capsule containing 18 enzymes plus ginger, fennel and peppermint. Twenty healthy adults with occasional post-meal bloating completed two pizza-meal visits one week apart. Waist-circumference distension favored the product at 30 and 90 minutes, while subjective bloating, gas and indigestion differences were not significant. The sponsor funded the trial and employed the author. [4]
How might they work?
Enzymes catalyze substrate-specific hydrolysis in the digestive lumen. Alpha-galactosidase cleaves oligosaccharides humans otherwise deliver to colonic bacteria; lactase cleaves lactose; lipase acts on triglycerides; proteases act on proteins.
The enzyme must remain active at the relevant pH and arrive with its substrate. Laboratory activity or plausible digestion does not establish a symptom benefit from a finished blend.
What are the risks and interactions?
Possible effects include abdominal discomfort, nausea, constipation or diarrhea. Microbial, fungal, papaya, pineapple and porcine sources can create allergy, dietary or religious concerns. Blends containing ginger, peppermint, betaine HCl or bile salts add separate risks and interactions.
Persistent weight loss, oily stools, anemia, bleeding, severe pain, vomiting or nocturnal symptoms need medical assessment rather than escalating an OTC blend. A suspected pancreatic disorder requires testing and clinician-directed PERT.
Regulatory status in the United States and Canada
In the United States, OTC blends are dietary supplements; prescription pancrelipase products are regulated drugs. In Canada, finished natural health products require an NPN and product-specific authorized claims. Neither market category makes a broad OTC blend equivalent to prescription PERT.
What should be monitored?
Record product and lot, each enzyme and unit, capsule count, meal and food substrate, timing, bloating, pain, stool pattern, allergy symptoms and stopping. For diagnosed insufficiency, keep prescribed lipase units and clinician instructions separate from supplement activity units.
What happens after stopping?
No withdrawal syndrome or taper is established. Meal-linked symptoms may return if a targeted enzyme was effective; symptoms caused by an underlying disease still need diagnosis and treatment.
How should they be stored?
Follow the label and protect from heat and moisture because enzymes are proteins whose activity can decline. Retain the expiry date and lot; an activity claim is meaningful only through the stated shelf life.
Community experiences
Anecdotes often omit meal composition and combine enzymes with herbs, acidifiers or bile. Improvement after a smaller meal cannot isolate the capsule. Targeted, repeated observations are more interpretable than a general “digestion” rating.
How do they compare with other approaches?
Dietary adjustment can directly reduce a known substrate. Lactase and alpha-galactosidase have focused purposes. Broad blends may be reasonable experiments for some people, but persistent symptoms should prompt assessment for lactose intolerance, celiac disease, pancreatic insufficiency, inflammatory disease or another cause.
Frequently asked questions
Are more enzymes better?
No. Relevance, activity, stability and the matching food substrate matter more than ingredient count.
What does GalU mean?
It is an assay unit for alpha-galactosidase activity, not milligrams of enzyme. [1]
What did the 2024 blend trial show?
Measured distension favored one proprietary enzyme-and-herb capsule after pizza; subjective symptom differences were not significant. [4]
Can an OTC blend replace PERT?
No. Prescription PERT is clinician-dosed treatment for diagnosed pancreatic insufficiency. [3][5]
When should the capsule be taken?
Use the studied or labeled timing. For meal digestion, the enzyme generally needs to arrive with its substrate; do not invent timing missing from a source.
Can enzymes cause allergy?
Yes. Source materials can include fungal organisms, pineapple, papaya or porcine pancreas.
Glossary
Terms used in this guide.
- Activity unit
- Assay-defined measure of how much substrate an enzyme converts under specified conditions.
- GalU
- Galactosidase activity unit used for alpha-galactosidase products and studies.
- Substrate
- Food molecule on which a particular enzyme acts.
- PERT
- Prescription pancreatic enzyme replacement therapy for diagnosed exocrine pancreatic insufficiency.
- Crossover trial
- Study in which participants receive more than one intervention in different periods.
How this guide was researched
This guide prioritizes two substrate-specific alpha-galactosidase trials, the full 2024 proprietary-blend report, an open clinical review and current medical guidance separating OTC blends from PERT. Source identities and correction notices were checked October 9, 2026.
How this guide was made
Method and evidence gaps
Protocols were extracted by enzyme identity, activity units, meal substrate, timing, follow-up and endpoint. The 2024 article’s full methods, funding and author disclosure were reviewed; its multi-ingredient design prevents enzyme-specific attribution.
Gaps: independent replication of broad blends, end-of-shelf-life activity verification, factorial trials separating enzymes from herbs, longer follow-up and head-to-head OTC product comparisons.
Sources
Start with the targeted enzyme trials, then inspect the proprietary blend and category review.
Showing 5 sources
- 01
The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms. ↗
Randomized double-blind placebo-controlled meal challenge
Eight healthy adults; 300 or 1,200 GalU with 420 g cooked beans; dose-specific gas and symptom findings.
- 02
A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients. ↗
Randomized double-blind placebo-controlled crossover pilot
20 adults; 1,200 GalU as 3 × 400 GalU capsules with the first bites of three high-oligosaccharide meals; no universal symptom benefit.
- 03
Digestive Enzyme Supplementation in Gastrointestinal Diseases. ↗
Narrative clinical review
Separates established replacement uses from emerging plant- and microbe-derived enzyme applications.
- 04
A Multi-Digestive Enzyme and Herbal Dietary Supplement Reduces Bloating in a Single Use in Healthy Adults ↗
Randomized double-blind placebo-controlled crossover trial
20 completers; one proprietary capsule with 18 enzymes and three herbs; industry funded, sponsor-employed author.
- 05
Digestive Enzymes and Digestive Enzyme Supplements ↗
Academic medical guidance
Distinguishes diagnosed enzyme insufficiency and prescription treatment from OTC supplement claims.
No matching sources
Try a different term or show the full list.